Matthew Harmelink
Neurology with Special Qualifications in Child Neurology · Milwaukee, WINPI 1497052021
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $107,476 of the $122,376 with a category attached, or 87.8%. Sarepta Therapeutics, Inc. accounts for 84.4% of it on its own, with 6 other manufacturers making up the rest. Among neurology with special qualifications in child neurology clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 76 payments — averaging $1610.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sarepta Therapeutics, Inc.$103K
- Pfizer$6K
- Novartis Gene Therapies, Inc. (fka Avexis, Inc.)$5K
- Biogen$4K
- PTC Therapeutics, Inc.$2K
- NS Pharma, Inc.$1K
- plus $1K from 1 others
Across 301 payments — averaging $1835.58 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sarepta Therapeutics, Inc.$388K
- Vertex$75K
- Novartis Gene Therapies, Inc. (fka Avexis, Inc.)$41K
- Novartis$29K
- Mallinckrodt Enterprises LLC$13K
- PTC Therapeutics, Inc.$4K
- plus $2K from 1 others
What the payments were for
- Consulting fees$107,47688%
- Speaking & faculty fees$8,1267%
- Travel & lodging$5,1064%
- Food & beverage$1,6551%
- Education$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sarepta Therapeutics, Inc. | 49 | $103,300 |
| Pfizer | 5 | $5,635 |
| Novartis Gene Therapies, Inc. (fka Avexis, Inc.) | 6 | $4,946 |
| Biogen | 8 | $3,835 |
| PTC Therapeutics, Inc. | 3 | $2,264 |
| NS Pharma, Inc. | 1 | $1,395 |
| Genentech, Inc. | 4 | $1,001 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZOLGENSMA$4,871
- Exondys 51$3,931
- SPINRAZA$3,603
- VILTEPSO$1,395
How this compares
$122,376 in reported general payments places this provider in the 95th percentile of 25 neurology with special qualifications in child neurology providers in Wisconsin.
See all neurology with special qualifications in child neurology providers in Wisconsin →
Other neurology with special qualifications in child neurology in Milwaukee
- Nancy BassMilwaukee$12K
- Avantika SinghMilwaukee$635
- Niyati MehtaMilwaukee$251
- Lileth Joy MondokMilwaukee$217
- Pradeep JavarayeeMilwaukee$139
- Sarah OswaldMilwaukee$115
- Elham AbushanabMilwaukee$115
- Virginia KaperickMilwaukee$93
- Rene Andrade MachadoMilwaukee$61
- John Whitinger IvMilwaukee$24
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.